Introduction
Oncolytic viruses can infect cancer cells, multiply selectively within them and cause cell death, with released mature viral particles that infect neighbouring cells. We have previously shown that the E1A CR2 deletion adenoviral mutant dl922-947 has considerable activity in ovarian cancer, and is more potent than both E1A wild-type adenoviruses and the E1B-55K mutant dl1520 (Onyx-015) (Leyton et al., 2006; Lockley et al., 2006) . dl922-947 replicates selectively in cells with abnormalities of the Rb pathway and the consequent G 1 -S checkpoint, findings seen in over 80% of human cancers (Sherr and McCormick, 2002) , including ovarian (Yaginuma et al., 1997) . However, the exact mechanisms by which adenoviruses cause cell death remain uncertain. A phase I trial of dl922-947 in women with relapsed ovarian cancer is imminent and understanding these mechanisms will be pivotal for further clinical development.
Adenovirus-induced cell death was long presumed to be classically apoptotic (Hall et al., 1998) . E1A induces potent apoptosis in many cell systems (Rao et al., 1992) , while E4orf4 can induce caspase-dependent cell death (Robert et al., 2002) . Adenoviruses also express several proteins that inhibit cell death early after infection; for example, E1B-19K is the viral homologue of Bcl-2 (Chiou et al., 1994) and E1B-55K, in concert with E4orf6, targets p53 for proteasomal destruction (Steegenga et al., 1998) . However, many of these studies investigated the expression of viral proteins in isolation, rather than in the context of productive infection, which may have led to oversimplified conclusions. Recently, two groups have made more systematic attempts to monitor selectively replicating viral mutants in human cancer cells. One used D24 and D24RGD in H460 non-small cell lung carcinoma cells (Abou El Hassan et al., 2004) . Both these vectors contain the same 24 bp E1A CR2 deletion as dl922-947, but D24 is entirely E3 deleted (Fueyo et al., 2000) , whereas D24RGD has an intact E3 region and an RGD motif in the fibre knob to redirect binding to a v integrins (Fueyo et al., 2003) . The second group used a mutant with a wild-type E1A region under the control of the human telomerase reverse transcriptase (hTERT) promoter in telomerase-positive cancer cells (Ito et al., 2006) . Their conclusions were dramatically different; Abou El Hassan used the term 'necrosis-like programmed cell death' to describe the actions of D24 viruses, whereas Ito concluded that autophagy contributed significantly to the death of glioma cells.
Here we show clearly that classical apoptosis does not occur in ovarian cancer cells treated with E1A CR2 mutant adenoviruses, nor do mitochondria play any determining role. We exclude a role for proteases such as cathepsins, and our data suggest that pure necrosis is not evident. We also show that autophagy is not the mechanism of cell death. Rather, autophagy appears to act as a cell survival response to adenovirus infection in ovarian cancer. Our overall conclusion is that adenovirus-induced cytotoxicity in ovarian cancer cells may constitute a novel mode of programmed cell death.
Results

Biochemical features of classical apoptosis in adenoviral cytotoxicity
We have previously shown that dl922-947 produces greater cytotoxicity in ovarian cancer cells than wild-type adenovirus type 5 and dl1520 . Infection of IGROV1 and OVCAR4 cells with dl922-947 and dlCR2 induced similar dose-dependent reductions in cell survival ( Figure 1a ). To investigate whether co-expression of the potent pro-apoptotic protein Smac/DIABLO could enhance viral activity, we constructed dlCR2 tSmac; cytotoxicity induced by this virus, however, never exceeded that induced by dlCR2 or dl922-947 (Figure 1a) , despite a dose-and time-dependent increase in processed Smac/DIABLO expression (not shown).
Since classical apoptosis had been the presumed mechanism of adenovirus-induced cell death and expression of Smac had no effect on viral efficacy, we investigated the role of apoptosis in adenoviral cytotoxicity. Using PhiPhi lux-G 1 D 2 , we showed that there was no detectable activation of caspase-3 72 h after infection of IGROV1 or OVCAR4 cells with any of the E1A CR2-deleted viruses, including dlCR2 tSmac. By contrast, 10 mM cisplatin, a classical apoptosis inducer, caused 90% of cells to activate caspase-3 ( Figure 1b) . The pan-caspase inhibitor zVAD-fmk had no effect on viral cytotoxicity (Figure 1c ), but was able to reduce cisplatin-induced death highly significantly (Figure 1d ). Western blotting showed only very minor activation of procaspase-3, but with some evidence of poly-ADP ribose polymerase (PARP) cleavage at 72 h (Figure 1e ).
IGROV1 and OVCAR4 cells were analysed for exposure of phosphatidylserine (PS) with Annexin V and change in mitochondrial membrane potential by tetramethylrhodamine ethyl ester perchlorate (TMRE) staining. Following viral infection, PS exposure was trivial and only found at late time points once cell membrane permeability had increased (Figure 2a) , a process that permits Annexin V entry into the cell. By contrast, 75% of cells treated with cisplatin for 72 h were Annexin V-positive (Figure 2c) . Similarly, the number of cells that had lost mitochondrial membrane potential, but not cell membrane potential, never exceeded 12% (Figure 2a ), whereas 19% of intact cells treated with cisplatin lost mitochondrial membrane potential (Figure 2c ). There was minimal hypodiploid DNA up to 96 h post infection, which coincided with the number of cells that had lost cell membrane integrity (Figure 2b ). By contrast, 90% of cisplatin-treated cells had hypodiploid DNA (Figure 2c ). These data suggest that classical apoptosis is not induced in ovarian carcinoma cells following infection with replicating adenovirus. To investigate whether adenovirus-infected cells were capable of undergoing apoptosis, IGROV1 cells co-treated with dl922-947 multiplicity of infection of 10 plaque-forming units per cell (MOI 10) and 3 mM cisplatin were assayed for markers of apoptosis. Results indicated that dual treated cells displayed enhanced features of apoptosis, suggesting that cisplatin was able to act in a 'dominant' manner ( Figure 2d ).
Mitochondria have no defining role in cell death caused by replicating adenovirus We further tested the role of mitochondria in viral cytotoxicity. Overexpression of Bcl-2 had no effect on viral cytotoxicity, but significantly reduced cisplatin sensitivity ( Figure 2e ). This is particularly significant, as the anti-apoptotic effects of Bcl-2 are mediated through mitochondria (Gross et al., 1999) and Bcl-2 is an important mediator of chemotherapy resistance in ovarian cancer (Opipari et al., 2004) . Second, cytochrome c release did not increase in virus-treated IGROV1 cells compared to untreated controls (Supplementary Figure  B) . Finally, cyclosporin A, the cyclophilin-D inhibitor, was found to have no effect on dl922-947 efficacy (Supplementary Figure C) . These data do not support a role for mitochondria or Bcl-2 in adenoviral cytotoxicity, as does the failure of Smac overexpression to augment cell death levels.
Lysosomes and autophagy act to promote cell survival Lysosomal proteases, such as cathepsins, can mediate non-classical apoptosis (Castino et al., 2002) . The cysteine protease inhibitor E64 (Figure 3a ) and the aspartic acid protease inhibitor pepstatin A (data not shown) had minimal effects dlCR2-or dl922-947-mediated cell death in IGROV1 and OVCAR4 cells, suggesting that the main lysosomal cathepsins, B and D, have little role in virus-mediated cell death. Examination of lysosomal stability using acridine orange (AO) staining indicated that infection with virus, in contrast to cisplatin treatment, caused lysosomes to stabilize (Figure 3b ), suggesting that lysosomal number or size increased in response to virus, despite an increase in oxidative stress.
Autophagy is a mechanism by which cells recycle organelles and can also be induced to combat infection (Terman et al., 2003) . It has been suggested as the main pathway of cell death with replicating adenoviral vectors in glioma cells (Ito et al., 2006) . During autophagy, a double-membraned autophagosome forms, engulfing cytoplasmic constituents, which later fuses with a lysosome to degrade the contents (Levine and Yuan, 2005) . To examine the role of autophagy in viral cytotoxicity, we first examined cells with transmission electron microscopy (TEM) and stained autophagosomes with monodansylcadaverine (MDC). Both techniques showed an increase in the number of autophagosomes with replicating virus infection. TEM showed a general increase in the number of vacuoles and lysosomes in the cytoplasm of virus-infected cells compared to controls (Figure 4a ). Many of these were doublemembraned and had contents that included other membranes, which forms the definition of an autophagosome, the early step of autophagy (Kroemer et al., 2005) . MDC staining confirmed early autophagosome formation (Figure 4b ), while co-infection of IGROV1 cells with dl922-947 and Ad GFP-LC3 showed punctate LC3 staining as it associates with autophagosome membranes (Figure 4c ). We then used 3-methyladenine (3MA), the class III phosphoinositide-3-kinase inhibitor, to block early autophagocytic signalling (Stroikin et al., 2004) , and chloroquine (CQ), a lysosomotropic drug that raises lysosomal pH and impairs autophagic protein degradation, the last step in the autophagic process (Amaravadi et al., 2007) . Both drugs augmented virus-induced death in a dose dependent manner (Figure 4d ), confirming that autophagy occurs in ovarian cancer cells following viral infection, but that it may have a protective role. Furthermore, inhibition of autophagy with 3MA and CQ did not increase the features of apoptosis, suggesting no alteration in the mode of cell death (Supplementary Figure D) .
Cell morphology and necrosis
Necrosis is often regarded as the default mode of cell death in the absence of apoptosis, and there are few wellvalidated assays compared to apoptosis. We examined gross cell morphology using phase-contrast microscopy. Virus-infected cells were rounded with some membrane blebbing. Cell rounding became more apparent with time, but there was no obvious rupture of membranes (Figure 5a ). We further examined cellular morphology using TEM. dlCR2 produced marked changes: viral particles were seen throughout the cell, with virions assembling in the nucleus. Other features included chromatin condensation, dilation of mitochondrial cristae, Golgi and endoplasmic reticulum, and disorganization of the cytoplasm (Figure 5b ). These features have all previously been described in association with apoptosis (Cereghetti and Scorrano, 2006) . By contrast, the non-replicating control virus Ad LM-X had a very limited effect. Hoechst 33342 staining did demonstrate some nuclear swelling in virus-infected cells (Supplementary Figure E ). This change is a potential marker of necrosis, but the TEM images suggest that this results from viral particle assembly. Hoechst 33342 staining following virus infection also showed some apoptotic features in occasional cells, but these were dramatically less than seen with cisplatin treatment and were absent in the vast majority of cells.
There are few biochemical markers of necrosis. However, a fall in intracellular adenosine triphosphate (ATP) levels is frequently seen (Lelli et al., 1998) . ATP levels increased following infection with all E1A CR2-deleted viruses and never fell below the level of the untreated control (Figure 5c ).
Discussion
These results provide evidence that classical apoptosis is not the mechanism by which replicating adenoviruses cause cell death. Some apoptotic morphological features are found, but there are dramatically fewer than with cisplatin treatment. The morphology is clearly strongly influenced by virus, as shown by the swollen nuclei with intra-nuclear virus assembly, as well as the large number of virions in cytoplasm and the increase in lysosomes and autophagosomes.
The complete lack of a defining role for mitochondria is especially striking, since they are central both to classical apoptosis and also some forms of necrosis (Baines et al., 2005) . Mitochondrial changes were induced by the virus, with some mitochondrial membrane potential loss and ballooning of cristae on TEM. However, these events did not drive cell death, as their modulation had no effect on overall cytotoxicity. IGROV1 and OVCAR4 cells can undergo mitochondria-dependent classical apoptosis in the presence of virus, as was evident in dominant response to cisplatin following dual treatment. However, this is selective, as co-expression of Smac had no effect, implying that viruses can inhibit some, but not all, forms of mitochondrial-dependent death. The lysosomal studies showed that cathepsins did not play a major role.
We also showed that autophagy may be a cell survival mechanism in the presence of virus, rather than a cell death pathway, as suggested recently (Ito et al., 2006; Jiang et al., 2007) . Treatment with 3MA and chloroquine caused a significant increase in cytotoxicity. Others have previously shown autophagy to be a survival mechanism in varied tumour models (Bauvy et al., 2001; Amaravadi et al., 2007) . Cells are also known to instigate autophagy as a defence mechanism in response to bacterial or viral infections (Talloczy et al., 2002 showing that this was the main cause of death rather than simply a cellular response to virus proved difficult. A single high concentration of 3MA (1 mM) was used, which caused only 18.3% change in cell viability; 1 mM 3MA is likely to have many non-specific effects (Caro et al., 1988) . By contrast, we were able to show that the 3MA and chloroquine effects depended upon both dose of virus and drug and that these drugs caused no change in the mode of cell death.
Proving the existence of necrosis is difficult in the absence of classical markers such as exist for apoptosis. We examined cellular morphology using three techniques and changes in ATP concentration. Although the eventual result of viral infection is lysis, adenoviral cytotoxicity does not fit a purely necrotic profile, as there is no wholesale disruption of cellular membranes and organelles nor a reduction in ATP concentration, typical features of necrosis. It was recently suggested that the E1A CR2-deleted virus D24 caused a type of cell death described as necrosis-like programmed cell death (Abou El Hassan et al., 2004) . Infection with viruses did not result in the appearance of apoptotic features, with the exception of PS exposure. However, the authors failed to examine any of the key features that would constitute pure necrosis and used the term necrosis to signify absence of (classical) apoptosis rather than necrosis itself. They also did not investigate other types of cell death or potential mechanisms of 'programming'. They themselves say the use of the term necrosis is arbitrary.
Others have previously suggested that viruses lacking E3 11.6, the adenovirus death protein (ADP), are less potent than those with an intact E3 region (Tollefson et al., 1996) . Our results also indicate that ADP does not affect either the mode or extent of viral cytotoxicity in ovarian cancer. All parameters investigated were evident in cells infected with both dl922-947 and dlCR2: indeed, dlCR2 induced many effects more rapidly than dl922-947, the cause of which is uncertain. Abou El Hassan also found that the nature of cell death was the same in glioma cells infected with D24 and D24RGD (Abou El Hassan et al., 2004) and suggested that the presence of E3 in D24RGD increased potency. However, this increased potency could equally have resulted from increased infectivity afforded by the RGD motif in glioma cells rather than the presence of E3. The mechanism of ADP activity remains elusive, although it is believed to bind to MAD2B (Ying and Wold, 2003) . Recent results suggest that deletions in the E1 region could compensate for absence of ADP in A549 cells (Subramanian et al., 2006) and, although E1A CR2 mutations were not specifically investigated, it is possible that deletions in this region could also enhance viral spread.
Replicating adenovirus-induced cell death may therefore be described as a strongly virus-controlled version of non-classical cell death, one that has not been fully characterized before. It is programmed, but with the ultimate control coming from virus rather than cell. This may explain the early cleavage of PARP, found despite the significant caspase activation. If PARP were not inactivated, necrosis could have occurred, as PARP activity can result in depletion of NAD þ and ATP levels (Zong et al., 2004) . The cells make a valiant attempt to undergo apoptosis, as witnessed by some of the morphological features found, but the control by the virus is sufficiently thorough that biochemical characteristics are effectively abolished. The virus uses the cell processes for its own ends, to replicate and assemble itself, and then causes cell lysis, although the final pathway of this lysis remains to be fully determined.
Materials and methods
Cell culture, adenoviral construction and cell viability assays IGROV1 and OVCAR4 were incubated at 37 1C with 5% CO 2 in air, in Dulbecco's modified Eagle's medium with 10% foetal bovine serum (FBS). Bcl2-overexpressing OVCAR4 cells were produced previously (McNeish et al., 2003) . dl922-947 is an Ad5 vector deleted in the region encoding amino acids 122-129 of the E1A CR2 domain as well as in E3B (Heise et al., 2000) . dlCR2 contains the same E1A CR2 deletion as dl922-947 and its construction is described elsewhere (Leyton et al., 2006) . To generate dlCR2 tSmac, an expression cassette consisting of the cytomegalovirus immediate-early promoter, the gene for processed Smac and a polyadenylation signal were ligated as a SalI fragment into pShuttle dlCR2 immediately downstream of E1, to create pShuttle dlCR2 tSmac. Viruses dlCR2 and dlCR2 tSmac were created by linearizing pShuttle dlCR2/ pShuttle dlCR2 tSmac with PmeI and recombining with pAd Easy1 in electrocompetent Escherichia coli. Virus was rescued following transfection of the recombinant plasmid into 293 cells, followed by amplification and purification using double density CsCl ultracentrifugation. Both dlCR2 and dlCR2 tSmac are entirely E3 deleted, corresponding to nucleotides 28130-30820 of the Ad5 genome (He et al., 1998) . PCR evaluation of E3 genes in dl922-947 and dlCR2 is presented in Supplementary Figure A . The E1-deleted control vector Ad LM-X is described elsewhere (McNeish et al., 2001) . Ad GFP-LC3 is described elsewhere (Bampton et al., 2005) and was a kind gift of Dr Aviva Tolkovsky (University of Cambridge, UK).
For cell viability assays, 10 4 cells were infected with adenovirus in serum-free medium and re-fed 2 h later with 5% FBS-containing medium. Cell viability was assayed by MTT and Trypan blue exclusion assays; both assays gave identical results. All viability assays were performed in both IGROV1 and OVCAR4 triplicate at least three times. Results from the two cell lines were always similar.
Western blots
Cells were lysed in 150 mM NaCl, 50 mM Tris (pH 7.5), 0.05% SDS, 1% Triton X-100. Antibody binding was visualized using enhanced chemiluminescence (Amersham Pharmacia, Bucks, UK). Caspase-3 antibody was obtained from Alexis Biochemicals, Nottingham, UK (catalogue no. ALX-804-305) and PARP and Bcl-2 antibodies from Santa Cruz Biotechnology, CA, USA (catalogue nos. sc-8007 and sc-509, respectively).
Flow cytometry
For AO analysis, cells were incubated for 15 min in the dark at 37 1C with 15 mg ml À1 AO, then analysed on a FacsCalibur (Becton Dickinson, Oxford, UK). For other analyses, cells were incubated with 40 nM TMRE (Invitrogen, Oregon, USA) for 10 min, washed in phosphate-buffered saline (PBS) and resuspended with Annexin V-Alexa 647 conjugate (2.5 mg ml À1 ) for 15 min. 4-6-Diamidino-2-phenylindole (DAPI; 1 mg ml À1 ) was then added. Cells were also incubated with 20 mM dihydroethidium for 30 min before washing and Annexin V and DAPI addition. For caspase activation analysis, cells were incubated for 60 min with 10 mM PhiPhiLux-G 1 D 2 substrate solution (OncoImmunin Inc., Gaithersburg, MD, USA) as per the manufacturer's instructions before DAPI addition, then analysed on a FACS LSRII (Becton Dickinson) and the data processed using FlowJo software (Tree Star, OR, USA). Samples were then fixed in 70% ice-cold ethanol for 30 min, washed twice in sub-G 1 buffer (192 mM Na 2 HPO 4 , 4 mM citric acid), treated with 100 mg ml À1 RNase and analysed for hypodiploid DNA after addition of 50 mg ml À1 propidium iodide (PI).
Assays of necrosis
For ATP assays, protein extracts were suspended in standard reaction buffer containing luciferase and luciferin according to the manufacturer's instructions (ATP Determination Kit; Invitrogen), and the luminescence read on a Thermo Labsystems Luminoskan Ascent luminometer.
Confocal microscopy
Cells were fixed in 4% paraformaldehyde (PFA) or a 6:3:1 ethanol:chloroform:acetic acid mix for 30 min at room temperature, then washed three times with PBS and incubated with 10 mg ml À1 Hoechst 33342 or 50 mM MDC for 15 min, washed three times in PBS and mounted onto slides. Slides were examined on a Zeiss LSM 510 Laser Scanning microscope.
Transmission electron microscopy IGROV1 cells were incubated with virus for 72 h. They were fixed in 4% PFA and 2.5% gluteraldehyde, postfixed in reduced osmium tetroxide followed by 1% tannic acid, washed in 1% sodium sulphate then water and dehydrated in a graded ethanol series. The preparation was then washed in propylene oxide, infiltrated with araldite/propylene oxide overnight and then with araldite alone and embedded in resin. Sections were cut, placed on copper grids and stained with uranyl acetate in methanol followed by Reynold's lead citrate and viewed in a JEOL 1010 TEM.
Statistics
All dose-response curves, Kaplan-Meier survival curves and statistical analyses were generated using GraphPad Prism version 4 (GraphPad Software, San Diego, CA, USA). All comparisons are two-tailed t-tests, unless otherwise stated.
